Patents/Assignees

Celgene Corporation

68 patents in portfolio

US12220417utility2025
Pharmaceutical Compositions Comprising (s)-2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-yl)methyl)benzyl)amino)isoindoline-1,3-dione and Methods of Using the Same
0 cites
US12215094utility2025
Solid Forms of 2-methyl-1-[(4-[6-(trifluoromethyl)pyridin-2-yl]-6-{[2-(trifluoromethyl)pyridin-4-yl]amino}-1,3,5-triazin-2-yl) Amino]propan-2-ol
0 cites
US12186311utility2025
Antiproliferative Compounds and Second Active Agents for Combined Use
0 cites
US12186370utility2025
ACTRIIB Ligand Trap Compositions and Uses Thereof
0 cites
US12178822utility2024
Methods of Treating Hematological Malignancies Using 2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-yl)methyl)benzyl)amino)isoindoline-1,3-dion
0 cites
US12103920utility2024
Cereblon Binding Compounds, Compositions Thereof, and Methods of Treatment Therewith
0 cites
US12103923utility2024
Methods of Treating Non-hodgkin Lymphoma Using 2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-yl)methyl)benzyl)amino)isoindoline-1,3-dione
0 cites
US12090147utility2024
Combination Therapy with 2-(4-chlorophenyl)-n-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide
0 cites
US12084499utility2024
Sirp-α Binding Proteins and Methods of Use Thereof
0 cites
US12064427utility2024
Pharmaceutical Compositions Comprising (s)-4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)oxy)methyl)benzyl)piperazin-1-yl)-3-fluorobenzonitrile and Methods of Using the Same
0 cites
US12064437utility2024
Methods for Treating Systemic Lupus Erythematosus and the Use of Biomarkers as a Predictor of Clinical Sensitivity to Therapies
0 cites
US12065423utility2024
Crystalline 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione Monohydrate, Compositions and Methods of Use Thereof
0 cites
US12053466utility2024
Antiproliferative Compounds and Bispecific Antibody Against BCMA and CD3 for Combined Use
0 cites
US12053482utility2024
Oral Formulations of Cytidine Analogs and Methods of Use Thereof
0 cites
US12049470utility2024
MK2 Inhibitors, the Synthesis Thereof, and Intermediates Thereto
0 cites
US12029738utility2024
Antiproliferative Compounds and Methods of Use Thereof
0 cites
US11945804utility2024
Substituted 4-aminoisoindoline-1,3-dione Compounds, Compositions Thereof, and Methods of Treatment Therewith
0 cites
US11931420utility2024
Combination Therapies Using an Anti-bcma Antibody Drug Conjugate (ADC) in Combination with a Gamma Secretase Inhibitor (GSI)
0 cites
US11919879utility2024
Carboxylic Acid Containing Azetidinyl Compounds for the Treatment of Neurodegenerative Diseases
0 cites
US11912644utility2024
Processes for the Preparation of ( S )-tert-butyl 4,5-diamino-5-oxopentanoate
0 cites

← PreviousPage 2 of 4Next →